|
Endometriosis
|
|
0.010 |
GeneticVariation
|
BEFREE |
Finally, a significant genetic effect was observed in both the dominant (AG+GG vs AA) and recessive models (GG vs AG+AA), indicating the presence of an association between the genotype of SNP rs710886 and the risk of endometriosis.
|
31595574 |
2020 |
|
Carcinoma of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we chose four single nucleotide polymorphisms (SNPs) in lncRNA-<i>PCAT1</i> (rs1026411 G>A, rs12543663 A>C, rs710886 T>C, and rs16901904 T>C) to investigate the association between genetic variant in lncRNA-<i>PCAT1</i> and susceptibility to lung cancer.
|
31464517 |
2019 |
|
Squamous cell carcinoma of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
Polymorphisms in rs710886 and rs16901904 were observed to be associated with lung squamous cell carcinoma risk (CC+CT vs. TT: OR<sup>a</sup> = 0.638, <i>p</i>* = 0.040 for rs710886; CC vs. TT: OR<sup>a</sup> = 2.582, <i>p</i>* = 0.033 and CC vs. TT+CT: OR<sup>a</sup> = 2.381, <i>p</i>* = 0.048 for rs16901904).
|
31464517 |
2019 |
|
Non-Small Cell Lung Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
However, polymorphisms in rs1026411 and rs710886 were observed to have significant associations with susceptibility to non-small cell lung cancer (AG vs. GG: odds ratio [OR]<sup>a</sup> = 0.701, <i>p</i>* = 0.020 and AA+AG vs. GG: OR<sup>a</sup> = 0.711 [superscript "a" refers to OR adjusted by age, gender, and smoking], <i>p</i>* = 0.017 [asterisks "*" refers to <i>p</i> adjusted by age, gender, and smoking] for rs1026411; CT vs. TT: OR<sup>a</sup> = 0.723, <i>p</i>* = 0.047 and CC+CT vs. TT: OR<sup>a</sup> = 0.729, <i>p</i>* = 0.038 for rs710886).
|
31464517 |
2019 |
|
Primary malignant neoplasm of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we chose four single nucleotide polymorphisms (SNPs) in lncRNA-<i>PCAT1</i> (rs1026411 G>A, rs12543663 A>C, rs710886 T>C, and rs16901904 T>C) to investigate the association between genetic variant in lncRNA-<i>PCAT1</i> and susceptibility to lung cancer.
|
31464517 |
2019 |
|
Malignant neoplasm of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we chose four single nucleotide polymorphisms (SNPs) in lncRNA-<i>PCAT1</i> (rs1026411 G>A, rs12543663 A>C, rs710886 T>C, and rs16901904 T>C) to investigate the association between genetic variant in lncRNA-<i>PCAT1</i> and susceptibility to lung cancer.
|
31464517 |
2019 |
|
Carcinoma of bladder
|
|
0.010 |
GeneticVariation
|
BEFREE |
This study indicates that genetic variants in lncRNA PCAT1 were associated with bladder cancer susceptibility and the SNP rs710886 may act as a potential biomarker for bladder cancer risk.
|
28627442 |
2017 |
|
Malignant neoplasm of urinary bladder
|
|
0.010 |
GeneticVariation
|
BEFREE |
This study indicates that genetic variants in lncRNA PCAT1 were associated with bladder cancer susceptibility and the SNP rs710886 may act as a potential biomarker for bladder cancer risk.
|
28627442 |
2017 |
|
Bladder Neoplasm
|
|
0.010 |
GeneticVariation
|
BEFREE |
This study indicates that genetic variants in lncRNA PCAT1 were associated with bladder cancer susceptibility and the SNP rs710886 may act as a potential biomarker for bladder cancer risk.
|
28627442 |
2017 |